Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

NCT05987696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult
Minimal Residual Disease

Interventions

DRUG: CD33/CLL1 dual CAR-NK cell
DRUG: Cyclophosphamid
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: CD33 CAR-NK cell
DRUG: super NK cell

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]